医药行业:临床数据核查收严利好CRO行业

来自 : www.zhonghui-sh.com/en/displ.. 发布时间：2021-03-24

Industry focus on news: on March 28, the CFDA has issued a \"drug clinical trial data verification procedures (provisional)\". Due to historical reasons, the good and evil people mixed up domestic generics industry, competition is intense, market concentration is not high. At present our country about 5000 drug production enterprises, the listed drug approval about 1, 70000, industry concentration degree is far lower than the international level, the reform of the supply side. In this context, countries
Related company stock movements
Asia Pacific pharmaceutical co.
28.48 + 1.666.19 %
Made by hualan bio-engineering
43.56-0.53-1.20%
Tiger medicine
27.16-0.81-2.90%
Home has launched a new version of GMP certification, clinical data verification, chemical drug registration classification reform, approval and generics consistency evaluation policy priority review, all is in order to promote the pharmaceutical industry supply side ? instead


2016年4月9日chemical drug registration classification reform, approval and generics consistency evaluation policy priority review, all is in order to pr...,医药行业:临床数据核查收严利好CRO行业